Timber pharmaceuticals announces adjournment of annual meeting

Basking ridge, nj, june 03, 2021 (globe newswire) -- via newmediawire -- timber pharmaceuticals, inc. ("timber" or the “company”) (nyse american: tmbr), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that on june 3, 2021 its 2021 annual meeting of stockholders (the “annual meeting”) was convened without a quorum. as a result, in order to provide stockholders additional time within which to vote their eligible shares to establish a quorum, the annual meeting was adjourned.
TMBR Ratings Summary
TMBR Quant Ranking